PPHF-CDC Partnership: Strengthening Public Health Laboratories
The major objective is to enhance and strengthen the work and functionality of public health laboratories both domestically and abroad. The overarching goal is to improve several aspects of public health laboratories. These areas include the following: improving public health laboratory infrastructure, increasing the capacity through workforce development, promoting quality laboratory practices, expanding and improving health security, promoting and supporting informatics, and enhancing communication linkages. The specific objective may include but are not limited to:
1.Assess public health infectious disease laboratory capabilities and capacities by conducting and analyzing formal and informal surveys and other methodologies.
2.Convene Committees/Task Forces/Workgroups to develop or review guidelines and recommendations on PHL laboratory capacity and quality laboratory practice.
3.Provide training and other resources to address knowledge and capacity gaps.
4.Convene forums to exchange knowledge and build communities of practice and promote the role of public health laboratories in infectious disease control, especially in emerging infectious diseases.
5.Provide programmatic and technical support to other focus areas, including policy, emergency preparedness, global health, informatics, and professional development.
General information about this opportunity
Last Known Status
Agency: Department of Health and Human Services
Office: Centers for Disease Control and Prevention
Type(s) of Assistance Offered
Formula Grants (Cooperative Agreements)
Patient Protection and Affordable Care Act (PL 111-148), Title IV, Section 4002 (Prevention and Public Health Fund) for expanded and sustained national investment in prevention and public health programs. This program is funded in part by 2015 Prevention and Public Health Funds (PPHF-2015), Section 301 and 317, 42 U.S.C 241 and 247b; Sections 301 and 317 of the Public Health Service Act (PHS Act), 42 USC, 241 and 247b as amended; and Funding is appropriated under Affordable Care Act (PL 111-148), Title IV, Section 4002 (Prevention and Pulbic Health Fund), Title IV, Section 4002.
Who is eligible to apply/benefit from this assistance?
Eligible applicants that can apply for this funding opportunity are listed below:
•Small, minority, and women-owned businesses
•Federally recognized or state-recognized American Indian/Alaska Native tribal governments
•American Indian/Alaska native tribally designated organizations
•Alaska Native health corporations
•Urban Indian health organizations
•Tribal epidemiology centers
•State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau)
•Political subdivisions of States (in consultation with States)
A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required. Attach with “Other Attachment Forms” when submitting via www.grants.gov.
Applicants must have experience with enhancing and strengthening the work and functionality of public health laboratories both domestically and abroad. The overarching goal is to improve several aspects of public health laboratories. The nation’s public is the ultimate recipient of benefits from this program.
Costs will be determined in accordance with OMB Circular No. A-87 for State and local governments. For all other nonprofit grantees, cost will be determined in accordance with HHS Regulations 45 CFR 74 Subpart Q. For-profit organizations’ costs are determined in accordance with the Federal Acquisition Regulations, 48 CFR 31. OMB Circular No. A-87 applies to this program. OMB Circular No. A-87 applies to this program. 2 CFR 200, Subpart E - Cost Principles applies to this program.
What is the process for applying and being award this assistance?
Preapplication coordination is required. Environmental impact information is not required for this program. This program is excluded from coverage under E.O. 12372.
This program is excluded from coverage under 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards. A letter of intent is required for this funding opportunity agreement.
To apply for this funding opportunity use application form PHS 5161. Application forms and instructions are available on www.grants.gov and/or the CDC web site, at the following Internet address: www.cdc.gov/od/pgo/forminfo.htm. If you do not have access to the Internet, or if you have difficulty accessing the forms on-line, you may contact the CDC Procurement and Grants Office Technical Information Management Section (PGO-TIM) staff at: 770-488-2700.
Applications will be evaluated for completeness and responsiveness by the agency program and CDC Procurement and Grants Office (PGO). CDC will not review incomplete and non-responsive applications. After review and approval, a notice of grant award (NoA) will be prepared and processed, along with appropriate notification to the public. Initial award provides funds for the first budget period (usually 12 months) and the NoA will indicate support recommended for the remainder of the project period, allocation of Federal funds by budget categories, and special conditions, if any.
Jul 01, 2015 to Jun 30, 2020
Approval/Disapproval Decision Time
From 90 to 120 days.
Cooperative agreement project periods are 1 to 5 years. Subject to availability of funds, after initial awards, projects may be renewed non-competitively contingent upon satisfactory progress by the recipient (as documented in required reports) and the determination that continued funding is in the best interest of the Federal government.
How are proposals selected?
Applicants will be evaluated on the review criteria described in the Funding Opportunity Announcements (FOAs). In general, the review and selection process of complete and responsive applications to the FOA consists of determination of the scientific and technical merit by objective or peer review, availability of funds, and relevance of program priorities and the priorities of DHHS. Refer to the FOA for additional review criteria. The budget is not scored.
How may assistance be used?
Project funds may be used for costs associated with planning, organizing, conducting, and supporting public health laboratory infrastructure programs, and for the implementation of other program elements as described in Section 050 above. CDC’s rules on allowable expenses must be followed. The purpose of the program is to enhance the work of public health laboratories in the U.S. and abroad. The program aims to promote quality public health laboratory practice, improve public health laboratory infrastructure, strengthen the public health laboratory system, and to develop a well-trained public health laboratory workforce in the U.S. and globally. It also aims to ensure laboratory preparedness for emerging infectious diseases or other biologic and chemical public health threats, promote technology transfer to ensure up-to-date technologies for the testing laboratory, and enhance communication linkages between state and local public health laboaratories and the clinical laboratory testing community improvement of public health laboaratory infrastructure, state-of-the-art training for the nation’s laboratorians to be prepared in dealing with public health threats, improving laboraty leadership capabilities, enhancing inter-laboratory communications. This award will be used for direct assistance funding.
What are the requirements after being awarded this opportunity?
Semi-annual reports from each entity awarded a grant, cooperative agreement, or contract, summarizing the activities undertaken and identifying any sub-grants or sub-contracts awarded (including the purpose of the award and the identity of the recipient), to be posted not later than 30 days after the end of each 6-month period. Congress directed HHS to provide information on activities and programs supported with resources from the Prevention and Public Health Fund (PPHF) to a public website. No cash reports are required. Annual progress reports are required. Semi-annual reports shall be posted on a public website. Federal Financial Reports are required 90 days after the end of the calendar quarter in which the budget period ends. Consult with CDC about performance monitoring activities.
In accordance with the provisions of 2 CFR 200, Subpart F - Audit Requirements, non-Federal entities that expend financial assistance of $750,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Non-Federal entities that expend less than $750,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in 2 CFR 200.503.
Financial records, including documents to support entries on accounting records and to substantiate charges to each grant, must be kept readily available for review by personnel authorized to examine HHS grant accounts. Records must be maintained for three years after the end of a budget period. If questions still remain, such as those raised as a result of audit, related records should be retained until the matter is completely resolved.
Other Assistance Considerations
Formula and Matching Requirements
Statutory formulas are not applicable to this program.
This program has no matching requirements.
This program does not have MOE requirements.
Length and Time Phasing of Assistance
Financial assistance is provided for a 12-month budget period with project periods of up to five years subject to the availability of funds and satisfactory progress of the grantee. See the following for information on how assistance is awarded/released: Grantee should consult with PGO for additional information.
Who do I contact about this opportunity?
Regional or Local Office
See Regional Agency Offices. For program technical assistance, contact:
David Delozier, Senior Project Officer
Department of Health and Human Services
Centers for Disease Control and Prevention
MS E56, 1600 Clifton Road
Atlanta, GA 30333
For financial, grants management, or budget assistance, contact:
Terrian Dixon Grants Management Specialist
Department of Health and Human Services
CDC Procurement and Grants Office
2920 Brandywine Road, MS K70
Atlanta, GA 30341
CDC Telecommunication for the hearing impaired or disabled is available: TTY (770) 488-2783.
David Delozier 2400 Century Center Blvd,
, Atlanta, Georgia 30345 Email: email@example.com
(Formula Grants (Cooperative Agreements)) FY 14 $27,500,000; FY 15 est $27,000,000; and FY 16 est $27,500,000 - Approximately $7,200,000 for FY2015 in cooperative agreement funding will be made available. Future year funding is subject to the availability of funds.
Range and Average of Financial Assistance
Subject to availability to Funds: Salaries FY 15 est. $27 million– FY 2016 est. $27.5 million, FY 2017 est. $28 million, FY 2018 est. $28.5 million, FY 2019 est. $29 million, FY 2020 est. $29.5 million. Total estimate: $169.5 million.
Regulations, Guidelines and Literature
42 CFR 45, basic grant administration policies of DHHS and PHS are also applicable, 46 CFR 74 and 45 CFR 92, PHS Grants Policy Statement, DHHS publication No. (OASH) 94-50,000 (Rev.) April 1, 1994
Examples of Funded Projects
Fiscal Year 2014: No Current Data Available Fiscal Year 2015: Subject to availability to Funds: Salaries FY 15 est. $27 million– FY 2016 est. $27.5 million, FY 2017 est. $28 million, FY 2018 est. $28.5 million, FY 2019 est. $29 million, FY 2020 est. $29.5 million. Total estimate: $169.5 million. Fiscal Year 2016: No Current Data Available